31 August 2018 - Deborah Wilkes
Premium
iNova Pharmaceuticals has agreed to acquire a portfolio of products from Australian company Probiotec for AUD13.5 million (USD16.5 million) in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.